Market Cap | 56.48K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -6.64M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -2.00% |
Sales | 40.09M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -49.00% |
Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -80.00% |
Recommedations | - | Quick Ratio | 0.14 | Shares Outstanding | 282.38M | 52W Low Chg | 100.00% |
Insider Own | 0.78% | ROA | 5.17% | Shares Float | 281.37M | Beta | 2.91 |
Inst Own | - | ROE | -59.21% | Shares Shorted/Prior | -/- | Price | 0.00020 |
Gross Margin | 23.28% | Profit Margin | -16.55% | Avg. Volume | 51,227 | Target Price | - |
Oper. Margin | 5.84% | Earnings Date | - | Volume | 15,900 | Change | 0.00% |
Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.